Controversial effigy of Turkish PM was part of Wiesbaden art Biennale
The German city of Wiesbaden has removed a large gold statue of Turkish president Recep Tayyip Erdoğan after it sparked clashes between his supporters and opponents.
Back in 2015, Royal Dutch Shell Plc and BP Plc cast doubt over the future of aging oil fields offshore Norway. A crash in crude prices and high operating costs threatened to shut them early, leaving millions of barrels in the ground.
Nio, a Chinese company that makes electric cars, has filed to go public on the New York Stock Exchange. The company said in a filing on Monday that it’s looking to raise as much as $1.8 billion in the initial public offering.
Arianespace’s lightweight Vega rocket has deployed the European Space Agency’s Aeolus climate science satellite Wednesday in an evening launch from the Centre Spatial Guyanais at Kourou, French Guiana. The mission set sail at the instantaneous launch opportunity timed at 18:20:09 local time (21:20 UTC).
Chinese smartphone firm Xiaomi has posted a $2.1 billion profit for its first quarter of business as a public company on account of growing smartphone and hardware sales.
Monday is an historic day for Greece as nearly a decade of external financial help comes to an end.
The Syriza-led government has managed to end a third bailout rescue, implementing all the measures demanded by creditors, despite earlier doubts whether the inexperienced party would manage to complete the arduous task.
Delegations from China, India, Italy and Spain that were supposed to meet with North Dakota’s bean, pea and lentil growers in September have canceled their visits because of trade tensions.
Bacteria found in the human gut could save countless lives by transforming type A or type B blood into type O.
At a meeting of the American Chemical Society today, Steve Withers of the University of British Colombia presented new research suggesting enzymes found in gut bacteria could effectively strip antigens from the two most common blood types. If successful, the discovery would essentially make most types of blood accessible to those who need it, regardless of their blood type.
Living in China in the early 2000s changed my perspective. I saw firsthand that the outside world’s view–China was good at copying but bad at innovating–was simply wrong. While many were focused on the low prices of Chinese imports and those eerily similar Chinese knockoffs of beloved Western gadgets and appliances, it was clear to me, from meeting companies like Baidu and Huawei, that something tectonic was happening. China, it turns out, was building a global artificial intelligence empire, and seeding the tech ecosystem of the future.